1993
DOI: 10.1016/0169-4758(93)90231-4
|View full text |Cite
|
Sign up to set email alerts
|

Practical progress and new drugs for changing patterns of leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
120
0
8

Year Published

1997
1997
2010
2010

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 211 publications
(130 citation statements)
references
References 41 publications
2
120
0
8
Order By: Relevance
“…Seu tratamento é feito à base de antimoniais pentavalentes (Sb +5 ), anfotericina B e pentamidinas (isotionato e mesilato), quimioterápicos de alto custo, usados por via parenteral, requerendo um período de administração prolongado, causando efeitos adversos, como: alterações cardíacas, renais, pancreáticas e hepáticas (Olliaro;Bryceson, 1997;Yardley, 2002).…”
Section: Introductionunclassified
“…Seu tratamento é feito à base de antimoniais pentavalentes (Sb +5 ), anfotericina B e pentamidinas (isotionato e mesilato), quimioterápicos de alto custo, usados por via parenteral, requerendo um período de administração prolongado, causando efeitos adversos, como: alterações cardíacas, renais, pancreáticas e hepáticas (Olliaro;Bryceson, 1997;Yardley, 2002).…”
Section: Introductionunclassified
“…(Croft, 1988;Who, 1996). A rising problem is the changing patterns of sensitivity in antimonials (Olliaro & Bryceson, 1993;Berman, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Antimony remains the therapeutic cornerstone in all regions; however, antimony is expensive, toxic and requires administration of high doses resulting in serious side effects. [11][12][13] Therefore, there remains an urgent need for development of less toxic drugs that are effective against all forms of leishmaniases. The search of new drugs against leishmaniasis, potentially compounds and their derivatives have been described in the literature.…”
Section: Introductionmentioning
confidence: 99%